Rachel Rosovsky /LinkedIn
Oct 31, 2025, 02:06
Rachel Rosovsky Presents STORM-PE RCT Results at VIVA 2025
Rachel Rosovsky, Hematologist at Massachusetts General Hospital, posted on LinkedIn:
”The first-and only-RCT demonstrating the efficacy of anticoagulation (AC) for the treatment of PE was conducted in 1960 and included 73 patients. Join us at VIVA 2025 to see how far we’ve come. On behalf of the entire STORM-PE team and in collaboration with PERT Consortium, I will be presenting the clinical and functional outcomes of the first RCT comparing mechanical thrombectomy plus AC versus AC alone in patients with acute intermediate–high-risk PE.
Robert Lookstein, Prof.Dr.Stavros Konstantinides, Ido Weinberg, John Moriarty, Sahil Parikh, Suhail Dohad, Richard Channick, Richard Davis, The PERT Consortium®”
Stay updated with Hemostasis Today.
Anticoagulation
Deep venous thrombosis
DVT
Health
Hematology
Hemostasis
Hemostasis Today
Ido Weinberg
John Moriarty
Medicine
PERT Consortium
Prof.Dr.Stavros Konstantinides
Pulmonary embolism
Rachel Rosovsky
Richard Channick
Richard Davis
Robert Lookstein
Sahil Parikh
STORM-PE
Suhail Dohad
thrombosis
Venous Thrombosis
VIVA 2025
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice